Adagio Therapeutics, Inc. Contracts & Agreements
50 Contracts & Agreements
- Business Finance (6 contracts)
- Business Operations (8)
- Human Resources (33)
- Intellectual Property (3)
- First Amendment to the Employment Agreement of Jeremy Gowler, dated April 11, 2024, by and between Invivyd, Inc. and Jeremy Gowler (Filed With SEC on April 12, 2024)
- Amendment No. 2 to the Cell Line License Agreement by and between the Registrant and WuXi Biologics (Hong Kong) Limited, dated March 13, 2024 (Filed With SEC on March 28, 2024)
- Employment Agreement by and between the Registrant and Julie Green, dated January 24, 2024 (Filed With SEC on March 28, 2024)
- Employment Agreement by and between the Registrant and Robert Allen, dated March 14, 2023 (Filed With SEC on March 28, 2024)
- Employment Agreement by and between the Registrant and Stacy Price, dated February 3, 2023 (Filed With SEC on March 28, 2024)
- First Amendment to the Employment Agreement of Peter Schmidt by and between the Registrant and Peter Schmidt, dated December 6, 2022 (Filed With SEC on March 28, 2024)
- Employment Agreement by and between the Registrant and Peter Schmidt, dated November 9, 2020 (Filed With SEC on March 28, 2024)
- Form of Indemnification Agreement with Executive Officers and Directors (Filed With SEC on March 28, 2024)
- 2021 Equity Incentive Plan and Forms of Stock Option Grant Notice, Stock Option Agreement, Exercise Notice, RSU Award Grant Notice and RSU Award Agreement (Filed With SEC on March 28, 2024)
- Description of the Registrants Common Stock (Filed With SEC on March 28, 2024)
- Controlled Equity OfferingSM Sales Agreement by and between the Company and Cantor Fitzgerald & Co., dated December 22, 2023 (Filed With SEC on December 22, 2023)
- Second Amended and Restated Commercial Manufacturing Services Agreement by and between the Company and WuXi Biologics (Hong Kong) Limited, dated September 19, 2023 (Filed With SEC on November 9, 2023)
- Amendment Number Two to the Collaboration Agreement by and between the Company and Adimab, LLC, dated September 19, 2023 (Filed With SEC on November 9, 2023)
- Employment Agreement, dated July 19, 2023, by and between Invivyd, Inc. and William Duke (Filed With SEC on September 5, 2023)
- First Amendment to the Employment Agreement of David Hering by and between the Company and David Hering, dated June 15, 2023 (Filed With SEC on August 10, 2023)
- Non-Employee Director Compensation Policy (Filed With SEC on May 11, 2023)
- Consulting Services Agreement, effective as of February 4, 2023, by and between the Registrant and RDBio Consulting LLC (Filed With SEC on May 11, 2023)
- Employment Agreement, dated September 17, 2022, by and between Invivyd, Inc. and Jeremy Gowler (Filed With SEC on December 6, 2022)
- 2021 Employee Stock Purchase Plan (Filed With SEC on November 10, 2022)
- 2021 Equity Incentive Plan and Forms of Stock Option Grant Notice, Stock Option Agreement, Notice of Exercise, RSU Award Grant Notice and RSU Award Agreement (Filed With SEC on November 10, 2022)
- 2020 Equity Incentive Plan and Forms of Stock Option Agreement, Notice of Stock Option Grant and Notice of Exercise (Filed With SEC on November 10, 2022)
- Consulting Services Agreement, effective as of October 13, 2022, by and between Invivyd, Inc. and Fred Driscoll (Filed With SEC on October 13, 2022)
- Form of Separation Agreement to be entered into between Invivyd, Inc. and Jane Pritchett Henderson (Filed With SEC on October 13, 2022)
- Employment Agreement, dated July 5, 2022, by and between Adagio Therapeutics, Inc. and David Hering, M.B.A (Filed With SEC on July 5, 2022)
- First Amendment to the Amended and Restated Employment Agreement of Jane Henderson by and between the Registrant and Jane Pritchett Henderson, dated March 18, 2022 (Filed With SEC on March 31, 2022)
- Employment Agreement by and between the Registrant and Jill Andersen, dated September 24, 2021 (Filed With SEC on March 31, 2022)
- First Amendment to the Amended and Restated Employment Agreement of David Hering by and between the Registrant and David Hering, dated February 23, 2022 (Filed With SEC on March 31, 2022)
- Non-Employee Director Compensation Policy (Filed With SEC on March 31, 2022)
- Description of Adagio Therapeutics, Inc. Common Stock (Filed With SEC on March 31, 2022)
- Amended and Restated Commercial Manufacturing Services Agreement by and between the Registrant and WuXi Biologics (Hong Kong) Limited, dated August 12, 2021 (Filed With SEC on November 15, 2021)
- Form of Executive Officer Employment Agreement (Filed With SEC on November 15, 2021)
- Employment Agreement by and between the Registrant and Rebecca Dabora, dated August 5, 2021 (Filed With SEC on September 20, 2021)
- Amended and Restated Employment Agreement by and between the Registrant and Lynn Connolly, dated August 5, 2021 (Filed With SEC on September 20, 2021)
- Employment Agreement by and between the Registrant and Tillman U. Gerngross, dated August 5, 2021 (Filed With SEC on September 20, 2021)
- Form of Employment Agreement to be entered into by and between the Registrant and Tillman U. Gerngross (Filed With SEC on August 4, 2021)
- Form of Amended and Restated Employment Agreement to be entered into by and between the Registrant and Lynn Connolly (Filed With SEC on August 4, 2021)
- Form of Employment Agreement to be entered into by and between the Registrant and Rebecca Dabora (Filed With SEC on August 4, 2021)
- Form of Employment Agreement to be entered into by and between the Registrant and Rebecca Dabora (Filed With SEC on August 2, 2021)
- Form of Amended and Restated Employment Agreement to be entered into by and between the Registrant and Lynn Connolly (Filed With SEC on August 2, 2021)
- Form of Employment Agreement to be entered into by and between the Registrant and Tillman U. Gerngross (Filed With SEC on August 2, 2021)
- Form of Indemnification Agreement with Executive Officers and Directors (Filed With SEC on August 2, 2021)
- 2021 Employee Stock Purchase Plan (Filed With SEC on August 2, 2021)
- 2021 Equity Incentive Plan and Forms of Stock Option Grant Notice, Stock Option Agreement, Notice of Exercise, RSU Award Grant Notice and RSU Award Agreement (Filed With SEC on August 2, 2021)
- Form of Underwriting Agreement (Filed With SEC on August 2, 2021)
- Second Amended and Restated Investors Rights Agreement, by and among the Registrant and certain of its stockholders, dated April 16, 2021 (Filed With SEC on July 16, 2021)
- Cell Line License Agreement by and between the Registrant and WuXi Biologics (Hong Kong) Limited, dated December 2, 2020 (Filed With SEC on July 16, 2021)
- Commercial Manufacturing Services Agreement by and between the Registrant and WuXi Biologics (Hong Kong) Limited, dated December 24, 2020 (Filed With SEC on July 16, 2021)
- Collaboration Agreement by and between the Registrant and Adimab, LLC, dated May 21, 2021 (Filed With SEC on July 16, 2021)
- Assignment and License Agreement by and between the Registrant and Adimab, LLC, dated July 8, 2020 (Filed With SEC on July 16, 2021)
- 2020 Equity Incentive Plan and Forms of Stock Option Agreement, Notice of Stock Option Grant and Notice of Exercise (Filed With SEC on July 16, 2021)